Elekta AB (publ) (EKTAY)
- Previous Close
7.67 - Open
7.60 - Bid --
- Ask --
- Day's Range
7.60 - 7.63 - 52 Week Range
6.52 - 8.62 - Volume
1,318 - Avg. Volume
9,374 - Market Cap (intraday)
2.968B - Beta (5Y Monthly) 1.02
- PE Ratio (TTM)
21.79 - EPS (TTM)
0.35 - Earnings Date Jun 5, 2024
- Forward Dividend & Yield 0.23 (2.95%)
- Ex-Dividend Date Feb 26, 2024
- 1y Target Est
--
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services. It also provides Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Geneva, an applicator for cervical cancer treatment; veterinary radiation therapy products; and Elekta Kaiku for personalized cancer care. In addition, the company offers stereotactic radiosurgery, such as Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Elekta Esprit. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.
elekta.comRecent News: EKTAY
Performance Overview: EKTAY
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EKTAY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EKTAY
Valuation Measures
Market Cap
2.93B
Enterprise Value
3.38B
Trailing P/E
21.67
Forward P/E
16.31
PEG Ratio (5yr expected)
0.64
Price/Sales (ttm)
1.71
Price/Book (mrq)
3.03
Enterprise Value/Revenue
1.99
Enterprise Value/EBITDA
11.57
Financial Highlights
Profitability and Income Statement
Profit Margin
7.86%
Return on Assets (ttm)
5.12%
Return on Equity (ttm)
14.44%
Revenue (ttm)
18.22B
Net Income Avi to Common (ttm)
1.43B
Diluted EPS (ttm)
0.35
Balance Sheet and Cash Flow
Total Cash (mrq)
2.35B
Total Debt/Equity (mrq)
69.66%
Levered Free Cash Flow (ttm)
1.66B
Research Analysis: EKTAY
Company Insights: EKTAY
EKTAY does not have Company Insights